TK1 and head and neck squamous cell carcinoma: Studies have demonstrated that FLT-PET can effectively monitor treatment response in HNSCC xenograft models and that early suppression of TK1 activity corresponds to decreased tracer uptake following radiation or EGFR-targeted therapy [13].